Latest News

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Safety concerns for patients undergoing anesthesia who use glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which are medications approved for diabetes and weight management, were revealed in a UTHealth Houston study published today in JAMA Surgery.

• share
• favorite_border

Semaglutide is a safe, effective therapy for a common fatty liver disease in people with HIV, according to the results of a clinical trial presented by UTHealth Houston.

• share
• favorite_border

Brian Dean, MBA, MPH, a highly respected health care executive with more than 25 years of experience leading health systems across the country, joins UTHealth Houston as executive vice president for health affairs, effective March 18.

• share
• favorite_border

Three commitments to improve food security, diet quality, and health outcomes for vulnerable communities, made by UTHealth Houston in partnership with local and national organizations, have been approved as part of the White House Challenge to end Hunger and Build Healthy Communities.

• share
• favorite_border

Across the United States, more babies born at 22 weeks’ gestation are admitted to neonatal intensive care units (NICUs) and surviving in increasing numbers, according to a new study led by UTHealth Houston.

• share
• favorite_border

In recognition of its expertise in treating SCN2A-related neurological disorders, UTHealth Houston has been designated as the first SCN2A Multidisciplinary Center by the FamilieSCN2A Foundation, the largest global advocacy organization for the group of disorders.

• share
• favorite_border

• share
• favorite_border

A life-threatening mold infection known as health care-associated Fusarium solani meningitis can be associated with a delayed, but devastating, injury to the brainstem and its blood supply among those infected, according to physicians from UTHealth Houston.

• share
• favorite_border

• share
• favorite_border

Using the Nutrition Facts labels to make food choices is significantly associated with healthy eating among eighth and 11th grade students in Texas, although the proportion of students using nutrition labels to make their food choices is low, according to research from UTHealth Houston.

• share
• favorite_border

Rates of re-excision after initial breast-conserving surgery in women with breast cancer remain high across the United States, leading to an increased cost of care and a higher risk of postoperative complications, according to new research from UTHealth Houston.

• share
• favorite_border

A medication that appeared to stabilize the function and shape of red blood cells in an earlier study for patients with sickle cell disease is now part of a Phase III clinical trial that is open for enrollment at UTHealth Houston.

• share
• favorite_border

After children experienced severe traumatic brain injury, the infusion of bone marrow mononuclear cells derived from the patient’s own bones led to less time spent in intensive care, less intense therapy, and, significantly, the structural preservation of white matter, which constitutes about half the total volume of the brain, according to new research from UTHealth Houston.

• share
• favorite_border

The body’s immune response to Epstein-Barr virus (EBV) may play a role in causing damage in people with multiple sclerosis, according to a new study led by UTHealth Houston.

• share
• favorite_border

A study led by principal investigator Alexander Testa, PhD, assistant professor, and co-investigator Jack Tsai, PhD, professor, from the Department of Management, Policy and Community Health with UTHealth Houston School of Public Health, was published recently in Social Science & Medicine.

• share
• favorite_border

The use of high-protease pancreatic replacement therapy demonstrated improvement in maladaptive behaviors, such as irritability, in preschool children with autism spectrum disorder (ASD), according to research conducted at 32 clinical sites, including UTHealth Houston.

• share
• favorite_border

Jacques Morcos, MD, a renowned neurosurgeon from University of Miami Health System, will join UTHealth Houston as the new chair of the Vivian L. Smith Department of Neurosurgery with McGovern Medical School at UTHealth Houston, effective today. Nitin Tandon, MD, former chair ad interim of the neurosurgery department, has taken on a new role as the first vice president for strategy and development at UTHealth Houston Neurosciences, effective Sept. 1.

• share
• favorite_border

The 12-month Teaching Kitchen Multi-site Trial combines evidence-based nutrition education with culinary learning to support behavior change. The study will assess the feasibility of the novel teaching kitchen program on health outcomes and well-being.

• share
• favorite_border

A five-year, $2 million grant to study the pharmacological effects of the areca nut, commonly known as the betel nut, was awarded to a UTHealth Houston researcher by the National Institute on Drug Abuse, part of the National Institutes of Health (NIH).

• share
• favorite_border

Though still a third-year student with McGovern Medical School at UTHealth Houston, Gabriela Grangeiro Cruz is already working to broaden the medical field’s, and the public’s, understanding of Alzheimer’s disease by studying ways to prevent the neurocognitive disorder, which affects 6 million people living in the U.S.

• share
• favorite_border

When Megan Speir’s 18-month-old daughter, Sofia, started drooling on one side of her mouth during bath time, Megan initially thought Sofia was playing with her.

• share
• favorite_border

McWilliams School of Biomedical Informatics at UTHealth Houston reached a funding landmark with 15 faculty members awarded 16 different grants totaling more than $31 million between August and October 2023. Each grant has a focus on medical artificial intelligence (AI) innovations and advancements in research or health care.

• share
• favorite_border

As part of a five-year, $3.9 million grant from the National Institutes of Health, Adriana Pérez, PhD, professor in the Department of Biostatistics and Data Science with UTHealth Houston School of Public Health in Austin, received a $1.9 million subcontract to determine the scope and drivers of low-value and unequal care for patients with Parkinson’s disease and Parkinson’s disease dementia.

• share
• favorite_border

A five-year, $5 million grant has been awarded by the National Cancer Institute (NCI) to the UTHealth Houston Institute for Implementation Science to support research and training in implementation science, with a focus on improving cancer control efforts in Mexico and Latin America.

• share
• favorite_border

A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

CATCH My Breath, an evidence-based vaping prevention program created by researchers from UTHealth Houston, is now being offered at New York City Public Schools, thanks to a partnership with CATCH Global Foundation and in collaboration with the New York Health Foundation and the New York City Department of Health and Mental Hygiene.

• share
• favorite_border

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

• share
• favorite_border

Two different regions of the brain are critical to integrating semantic information while reading, which could shed more light on why people with aphasia have difficulty with semantics, according to new research from UTHealth Houston.

• share
• favorite_border

A five-year, $6.4 million grant to develop an integrated, multiscale artificial intelligence (AI) approach to study genetic factors associated with Alzheimer’s disease has been awarded to UTHealth Houston by the National Institute on Aging, part of the National Institutes of Health.

• share
• favorite_border

• share
• favorite_border

Demetrios Stroubakis, 55, thought he was having a gallbladder attack when he arrived at the emergency room in August 2021 with jaundice. Instead, he was shocked to be diagnosed with pancreatic cancer.

• share
• favorite_border

The offspring of adolescent and young adult women with a history of cancer face a higher risk of birth defects, according to new research from UTHealth Houston.

• share
• favorite_border

A four-year, $2.9 million grant to assess the implementation of real-time health intervention to decrease substance use and support HIV prevention strategies in young adults experiencing homelessness.

• share
• favorite_border

Today, as Aisha Atkinson sees her smiling 5-year-old son Aries walking independently, humming the melodies of his favorite pop songs, she is proud of how far her son has come since he entered the world with two massive brain bleeds that developed into hydrocephalus and, consequently, cerebral palsy, a neurological condition that affects mobility and posture.

• share
• favorite_border

Michigan native Ruth Bischoff, 69, had tried everything – multiple spine surgeries, a radiofrequency ablation, acupuncture, a spinal cord stimulator, and more – but she couldn’t find any relief from the shooting pain in her lower back that prevented her from standing up straight and walking.

• share
• favorite_border

As one of just six sites in the country chosen for a new consortium of the National Institutes of Health (NIH), UTHealth Houston School of Public Health in Brownsville will use multi-omics in combination with environmental, epidemiologic, and clinical data, along with social determinants of health, to study non-alcoholic and non-viral liver disease in Hispanics/Latinos.

• share
• favorite_border

A five-year, $3.3 million grant to study symptom management in patients with head and neck cancer has been awarded to researchers from UTHealth Houston by the National Cancer Institute (1R01CA282149), part of the National Institutes of Health.

• share
• favorite_border

A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD, with UTHealth Houston, insight into understanding the cause of a rare and progressive problem with arteries in the brain and a cause of strokes in young children, called moyamoya disease.

• share
• favorite_border

• share
• favorite_border

A three-year, $2.3 million grant to study post-pandemic eviction stress and mental health has been awarded to researchers from UTHealth Houston by the National Institute of Nursing Research, part of the National Institutes of Health.

• share
• favorite_border

A $2.5 million grant for the transformation of knowledge and treatment of bipolar disorder has been awarded to researchers at UTHealth Houston by Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²).

• share
• favorite_border

Tissue-sparing treatments using focal therapy, aimed to avoid side effects like urinary incontinence, are becoming available for prostate cancer patients like Morton McPhail of Texas.

• share
• favorite_border

The implementation of artificial intelligence-powered large vessel occlusion (LVO) detection software for acute stroke triage can improve endovascular thrombectomy treatment times, according to new research from UTHealth Houston.

• share
• favorite_border

The Bachelor of Science in Nursing (BSN) program at Cizik School of Nursing at UTHealth Houston topped all other undergraduate nursing programs in Texas, according to the 2024 U.S. News Best Colleges publication, which was released today.

• share
• favorite_border

R.Á.P.I.D.O., a culturally relevant acronym created under the leadership of Jennifer Beauchamp, PhD, RN, at Cizik School of Nursing at UTHealth Houston to raise awareness of stroke signs in the Spanish-speaking Hispanic/Latino community and save lives, has been adopted by the American Stroke Association (ASA), the organization announced today.

• share
• favorite_border

A five-year, $3.3 million grant to develop a molecular diagnostic test for congenital syphilis has been awarded to researchers from UTHealth Houston by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health.